Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs WINDLAS BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES WINDLAS BIOTECH ZIM LABORATORIES/
WINDLAS BIOTECH
 
P/E (TTM) x 29.6 - - View Chart
P/BV x 1.2 3.1 37.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ZIM LABORATORIES   WINDLAS BIOTECH
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
WINDLAS BIOTECH
Mar-21
ZIM LABORATORIES/
WINDLAS BIOTECH
5-Yr Chart
Click to enlarge
High Rs131NA-   
Low Rs53NA-   
Sales per share (Unadj.) Rs189.2667.1 28.4%  
Earnings per share (Unadj.) Rs4.524.6 18.3%  
Cash flow per share (Unadj.) Rs14.244.8 31.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %0NM- 
Book value per share (Unadj.) Rs99.0310.6 31.9%  
Shares outstanding (eoy) m16.246.41 253.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.50-   
Avg P/E ratio x20.50-  
P/CF ratio (eoy) x6.50-  
Price / Book Value ratio x0.90-  
Dividend payout %00-   
Avg Mkt Cap Rs m1,4970-   
No. of employees `000NANA-   
Total wages/salary Rs m358583 61.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,0734,276 71.9%  
Other income Rs m2331 75.6%   
Total revenues Rs m3,0964,307 71.9%   
Gross profit Rs m346331 104.6%  
Depreciation Rs m158130 121.8%   
Interest Rs m10913 844.8%   
Profit before tax Rs m102219 46.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2962 47.2%   
Profit after tax Rs m73157 46.5%  
Gross profit margin %11.37.7 145.5%  
Effective tax rate %28.528.2 101.1%   
Net profit margin %2.43.7 64.7%  
BALANCE SHEET DATA
Current assets Rs m1,9181,943 98.7%   
Current liabilities Rs m1,420934 152.0%   
Net working cap to sales %16.223.6 68.6%  
Current ratio x1.42.1 64.9%  
Inventory Days Days1625 63.5%  
Debtors Days Days85868 1,266.1%  
Net fixed assets Rs m1,3041,018 128.1%   
Share capital Rs m16264 253.3%   
"Free" reserves Rs m1,4451,927 75.0%   
Net worth Rs m1,6081,991 80.7%   
Long term debt Rs m2188 2,623.7%   
Total assets Rs m3,2222,961 108.8%  
Interest coverage x1.918.0 10.8%   
Debt to equity ratio x0.10 3,249.9%  
Sales to assets ratio x1.01.4 66.0%   
Return on assets %5.75.8 98.3%  
Return on equity %4.67.9 57.6%  
Return on capital %11.611.6 99.7%  
Exports to sales %67.40-   
Imports to sales %4.10-   
Exports (fob) Rs m2,072NA-   
Imports (cif) Rs m127NA-   
Fx inflow Rs m2,1400-   
Fx outflow Rs m1270-   
Net fx Rs m2,0120-   
CASH FLOW
From Operations Rs m319115 278.1%  
From Investments Rs m-59-202 29.1%  
From Financial Activity Rs m-2608 -3,347.2%  
Net Cashflow Rs m-1-21 3.2%  

Share Holding

Indian Promoters % 33.3 60.0 55.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 17.0 -  
FIIs % 0.0 6.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 40.1 166.6%  
Shareholders   4,610 108,818 4.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   ORTIN LABS   MERCURY LAB.  GLAND PHARMA  RAYMED LABS  MANGALAM DRUGS  



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZIM LABORATORIES SHARE PRICE


Dec 3, 2021 (Close)

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES - AVON ORGANIC COMPARISON

COMPARE ZIM LABORATORIES WITH

MARKET STATS